Sichuan Hebang Biotechnology (603077.SS) Earnings Analysis
Sichuan Hebang Biotechnology (603077.SS) has no confirmed upcoming earnings date. Trailing P/E -50.74.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 603077.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 603077.SS. This page updates as the calendar is published.
603077.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-04-28 | -0.02005 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.0012 CNY | n/a | n/a | n/a |
| 2024-08-29 | 0.0196 CNY | n/a | n/a | n/a |
603077.SS valuation and analyst view
| Trailing P/E | -50.74 |
|---|---|
| Trailing EPS | -0.04693 CNY |
| Price / book | 1.06 |
| Dividend yield | 0.00% |
| Market cap | 18.87B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Sichuan Hebang Biotechnology (603077.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 603077.SS. This page updates as the calendar is published.
Did 603077.SS beat earnings last quarter?
Consensus estimate data was not available for 603077.SS's 2025-04-28 report.
What is 603077.SS's current P/E ratio and EPS?
603077.SS trades at a trailing P/E of -50.74 on trailing EPS of -0.04693208599696421 CNY.
What do analysts rate 603077.SS?
603077.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.